Aethlon Medical, Inc.
AEMD
$1.39
$0.0251.83%
| Weiss Ratings | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.99 | |||
| Price History | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.82% | |||
| 30-Day Total Return | -18.34% | |||
| 60-Day Total Return | -24.18% | |||
| 90-Day Total Return | -31.00% | |||
| Year to Date Total Return | -36.26% | |||
| 1-Year Total Return | -65.04% | |||
| 2-Year Total Return | -87.68% | |||
| 3-Year Total Return | -92.74% | |||
| 5-Year Total Return | -98.78% | |||
| 52-Week High % Change | -69.94% | |||
| 52-Week Low % Change | 11.33% | |||
| Price | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $7.20 | |||
| 52-Week Low Price | $1.35 | |||
| 52-Week Low Price (Date) | Apr 17, 2024 | |||
| 52-Week High Price (Date) | Apr 20, 2023 | |||
| Valuation | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.83M | |||
| Enterprise Value | -3.14M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -5.11 | |||
| Earnings Per Share Growth | -31.23% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 6.40 | |||
| Price/Book (Q) | 0.50 | |||
| Enterprise Value/Revenue (TTM) | -5.27 | |||
| Price | $1.38 | |||
| Enterprise Value/EBITDA (TTM) | 0.27 | |||
| Enterprise Value/EBIT | 0.26 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.52M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 619 941 0360 | |||
| Address | 11555 Sorrento Valley Road San Diego, CA 92121 | |||
| Website | www.aethlonmedical.com | |||
| Country | United States | |||
| Year Founded | 1999 | |||
| Profitability | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -2,047.31% | |||
| Profit Margin | -2,133.35% | |||
| Management Effectiveness | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -47.16% | |||
| Return on Equity | -- | |||
| Income Statement | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 574.20K | |||
| Total Revenue (TTM) | 574.20K | |||
| Revenue Per Share | $0.23 | |||
| Gross Profit (TTM) | 574.20K | |||
| EBITDA (TTM) | -11.40M | |||
| EBIT (TTM) | -11.76M | |||
| Net Income (TTM) | -12.25M | |||
| Net Income Avl. to Common (TTM) | -12.25M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -21.63% | |||
| EPS Diluted (TTM) | -5.11 | |||
| EPS Diluted Growth (Q YOY) | -10.91% | |||
| Balance Sheet | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.97M | |||
| Cash Per Share (Q) | $3.17 | |||
| Total Current Assets (Q) | 8.25M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 7.61M | |||
| Current Ratio (Q) | 3.927 | |||
| Book Value Per Share (Q) | $2.93 | |||
| Total Assets (Q) | 10.44M | |||
| Total Current Liabilities (Q) | 2.10M | |||
| Total Debt (Q) | 1.01M | |||
| Total Liabilities (Q) | 2.83M | |||
| Total Common Equity (Q) | 7.61M | |||
| Cash Flow | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -257.30K | |||
| Cash from Financing (TTM) | 1.24M | |||
| Net Change in Cash (TTM) | -9.53M | |||
| Levered Free Cash Flow (TTM) | -5.87M | |||
| Cash from Operations (TTM) | -10.51M | |||
